Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSIW) Other Non-Current Liabilities (2022 - 2025)

Historic Other Non-Current Liabilities for TriSalus Life Sciences (TLSIW) over the last 4 years, with Q3 2025 value amounting to $12.8 million.

  • TriSalus Life Sciences' Other Non-Current Liabilities rose 6364.57% to $12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year increase of 6364.57%. This contributed to the annual value of $8.3 million for FY2024, which is 5536.71% down from last year.
  • Per TriSalus Life Sciences' latest filing, its Other Non-Current Liabilities stood at $12.8 million for Q3 2025, which was up 6364.57% from $10.0 million recorded in Q2 2025.
  • Over the past 5 years, TriSalus Life Sciences' Other Non-Current Liabilities peaked at $22.6 million during Q1 2024, and registered a low of $369000.0 during Q4 2022.
  • For the 4-year period, TriSalus Life Sciences' Other Non-Current Liabilities averaged around $11.2 million, with its median value being $9.7 million (2025).
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first soared by 494932.25% in 2023, then crashed by 5818.3% in 2025.
  • TriSalus Life Sciences' Other Non-Current Liabilities (Quarter) stood at $369000.0 in 2022, then skyrocketed by 4949.32% to $18.6 million in 2023, then tumbled by 55.37% to $8.3 million in 2024, then surged by 53.73% to $12.8 million in 2025.
  • Its Other Non-Current Liabilities was $12.8 million in Q3 2025, compared to $10.0 million in Q2 2025 and $9.5 million in Q1 2025.